• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一名持续非卧床腹膜透析患者在治疗土曲霉腹膜炎后成功进行肾移植。

Successful renal transplantation following treatment of Aspergillus terreus peritonitis in a continuous ambulatory peritoneal dialysis patient.

作者信息

Varughese S, Mathews M S, Tamilarasi V

机构信息

Department of Nephrology, Christian Medical College, Vellore, India.

出版信息

Indian J Nephrol. 2011 Jul;21(3):208-11. doi: 10.4103/0971-4065.78069.

DOI:10.4103/0971-4065.78069
PMID:21886985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3161443/
Abstract

Peritoneal dialysis (PD) related peritonitis caused by fungi is a potentially life-threatening complication. It diminishes prospects of continuing PD. We report a patient with Aspergillus terreus peritonitis treated successfully with catheter removal and antifungal therapy and subsequently had a live-related renal transplantation. There was no recurrence of the infection in 3 years of follow-up.

摘要

真菌引起的腹膜透析（PD）相关腹膜炎是一种潜在的危及生命的并发症。它降低了继续进行腹膜透析的可能性。我们报告了一名患有土曲霉腹膜炎的患者，通过拔除导管和抗真菌治疗成功治愈，随后接受了活体亲属肾移植。在3年的随访中感染没有复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/3161443/a9ec6c14455e/IJN-21-208-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/3161443/b41f3318cb32/IJN-21-208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/3161443/cc5a14fc9465/IJN-21-208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/3161443/a9ec6c14455e/IJN-21-208-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/3161443/b41f3318cb32/IJN-21-208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/3161443/cc5a14fc9465/IJN-21-208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/3161443/a9ec6c14455e/IJN-21-208-g003.jpg

相似文献

1
Successful renal transplantation following treatment of Aspergillus terreus peritonitis in a continuous ambulatory peritoneal dialysis patient.一名持续非卧床腹膜透析患者在治疗土曲霉腹膜炎后成功进行肾移植。
Indian J Nephrol. 2011 Jul;21(3):208-11. doi: 10.4103/0971-4065.78069.
2
Peritonitis due to Aspergillus terreus in a patient undergoing continuous ambulatory peritoneal dialysis.一名持续非卧床腹膜透析患者发生土曲霉所致腹膜炎。
Mycoses. 2008 Mar;51(2):174-6. doi: 10.1111/j.1439-0507.2007.01465.x.
3
Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: report of 2 cases and review of the literature.腹膜透析患者曲霉和接合菌所致腹膜炎：2例报告及文献复习
Diagn Microbiol Infect Dis. 2003 May;46(1):49-54. doi: 10.1016/s0732-8893(02)00554-0.
4
Successful treatment of Aspergillus peritonitis in a peritoneal dialysis patient.一名腹膜透析患者的曲霉性腹膜炎得到成功治疗。
Pediatr Nephrol. 2002 Apr;17(4):243-5. doi: 10.1007/s00467-002-0821-6.
5
Aspergillus peritonitis: therapy, survival, and return to peritoneal dialysis.曲霉性腹膜炎：治疗、生存率及恢复腹膜透析情况
Am J Kidney Dis. 1995 Jul;26(1):80-3. doi: 10.1016/0272-6386(95)90158-2.
6
Aspergillus peritonitis in peritoneal dialysis patients: A systematic review.腹膜透析患者中的曲霉菌腹膜炎：一项系统性综述。
J Mycol Med. 2020 Dec;30(4):101037. doi: 10.1016/j.mycmed.2020.101037. Epub 2020 Aug 20.
7
Aspergillus peritonitis in continuous ambulatory peritoneal dialysis patients.持续性非卧床腹膜透析患者的曲霉性腹膜炎
Am J Nephrol. 2000 Jul-Aug;20(4):329-31. doi: 10.1159/000013609.
8
Successful treatment of Aspergillus peritonitis complicating peritoneal dialysis.
Am J Kidney Dis. 1989 Jun;13(6):501-3. doi: 10.1016/s0272-6386(89)80009-5.
9
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析患者的真菌性腹膜炎
Eur J Clin Microbiol Infect Dis. 1998 Dec;17(12):839-43. doi: 10.1007/s100960050203.
10
Aspergillus fumigatus peritonitis in ambulatory peritoneal dialysis: a case report and notes on the therapeutic approach.门诊腹膜透析患者的烟曲霉腹膜炎：一例病例报告及治疗方法说明
Nephrology (Carlton). 2005 Jun;10(3):270-3. doi: 10.1111/j.1440-1797.2005.00370.x.

本文引用的文献

1
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single-centre experience in India.持续性非卧床腹膜透析患者的真菌性腹膜炎：印度一家单中心的经验
Nephron Clin Pract. 2008;110(4):c207-12. doi: 10.1159/000167867. Epub 2008 Oct 31.
2
Peritonitis due to Aspergillus terreus in a patient undergoing continuous ambulatory peritoneal dialysis.一名持续非卧床腹膜透析患者发生土曲霉所致腹膜炎。
Mycoses. 2008 Mar;51(2):174-6. doi: 10.1111/j.1439-0507.2007.01465.x.
3
Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B.
毛霉病性腹膜炎：脂质体两性霉素B治疗失败后泊沙康唑挽救治疗后无病随访超过2年
Am J Kidney Dis. 2008 Feb;51(2):302-6. doi: 10.1053/j.ajkd.2007.09.026.
4
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.曲霉病的治疗：美国传染病学会临床实践指南
Clin Infect Dis. 2008 Feb 1;46(3):327-60. doi: 10.1086/525258.
5
Peritonitis due to Cunninghamella bertholletiae in a patient undergoing continuous ambulatory peritoneal dialysis.一名持续非卧床腹膜透析患者发生拜氏 Cunninghamella 引起的腹膜炎。
J Med Microbiol. 2006 Jan;55(Pt 1):115-118. doi: 10.1099/jmm.0.46202-0.
6
Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy.卡泊芬净联合两性霉素B治疗腹膜透析相关真菌性腹膜炎
Nephrol Dial Transplant. 2006 Jan;21(1):236-7. doi: 10.1093/ndt/gfi162. Epub 2005 Nov 1.
7
Fungal peritonitis in peritoneal dialysis patients.腹膜透析患者的真菌性腹膜炎
Perit Dial Int. 2005 May-Jun;25(3):207-22.
8
[Successful treatment with micafungin (MCFG) of severe peritonitis due to Candida parapsilosis with chronic renal failure patient on hemodialysis].[米卡芬净（MCFG）成功治疗患有慢性肾衰竭且正在接受血液透析的患者的近平滑念珠菌所致严重腹膜炎]
Kansenshogaku Zasshi. 2005 Mar;79(3):195-200. doi: 10.11150/kansenshogakuzasshi1970.79.195.
9
Peritoneal dialysis-related infections recommendations: 2005 update.腹膜透析相关感染的建议：2005年更新版
Perit Dial Int. 2005 Mar-Apr;25(2):107-31.
10
Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.土曲霉：血液系统恶性肿瘤患者中一种新出现的对两性霉素B耐药的机会性霉菌。
Cancer. 2004 Oct 1;101(7):1594-600. doi: 10.1002/cncr.20554.